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Abstract  
Background: In line with NICE guidance, an NHS commissioned case management intervention was 
provided for individuals receiving Incapacity Benefit payments for three years or more in the North 
East of England. The intervention aimed to improve the health of participants. 
Methods: 131 participants receiving the intervention were compared over nine months with a (non-
equivalent) comparison group of 229 receiving Incapacity Benefit payments and usual care. Health 
was measured using EQ-5D, EQ-VAS, SF-8 HADS and the Nordic Musculoskeletal questionnaire. 
Socio-demographic and health behaviour data were also collected. Fixed effects linear models with 
correlated errors were used to compare health changes between groups over time. A preliminary 
cost-utility analysis was also conducted. 
Results: Comparison group measures of health were stable over time. Starting from comparatively 
poor initial levels, case management group generic (EQ5D, EQ-VAS) and mental health (HADS-A, 
HADS-D and SF8-MCS) measures improved within six months to similar levels found in the 
comparison group. Musculoskeletal (Nordic 2) and health behaviours did not improve. Tentative 
estimates of cost-utility suggest the intervention cost in the region of £16,700 to £23,500 per QALY.  
Conclusion: Case management interventions may improve the health of incapacity benefit recipients.  
Further research is required to help confirm these pilot findings.   
 
200 words 
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Background 
Poor health is a significant risk factor for worklessness, as well as remaining out of work [1]. In most 
advanced market democracies, long-term health-related worklessness carries an entitlement to 
receipt of financial support from the welfare state in the form of sickness and disability payments or, in 
the case of the UK, incapacity-related benefits (Incapacity Benefit or Employment and Support 
Allowance). Rates of receipt of these benefits have increased from 0.5 million recipients in 1975 to 2.6 
million in 2007 - around 7% of the UK working age population, accounting for 11% of UK social 
security expenditure or 1.8% of gross domestic product (GDP) [2].  
 
This is an increasingly prominent policy concern in the UK with various welfare-to-work interventions 
initiated since the 1990s (for an overview see [3]). The effectiveness of such interventions in 
increasing labour activity amongst incapacity-related benefit (IB) recipients has been questioned by 
numerous evaluations [4;5;6]. A number of different reasons have been suggested for the lack of 
effectiveness, including lack of demand side interventions [5], scarcity of jobs [7], and the lack of 
attention paid to the barriers to employment imposed by ill-health [8;9]. The latter has led to calls for 
welfare to work interventions to take more of a ‘health first’ approach [8].  
 
Additionally, the 2008 Black review of the health of the working age population has played a key role 
in initiating a wider debate about work and health in general [10]. This resulted in the introduction of a 
“Fit Note” to general practice to replace the traditional sick note as well as the initiation in 2009 of 
eleven “Fit for work” pilots across the UK (seven of which are still running and will continue until 
March 2013) [10] which aim to test the impact of biopsychosocial case management interventions on 
return to work [10]. This was followed up by a comprehensive review of sickness absence 
arrangements to identify ways of reducing labour market drop-out as a result of ill health and sickness 
absence [11].   
   
In 2009, the National Institute for Health and Clinical Excellence (NICE) produced guidelines on the 
management of incapacity and sickness absence [12; 2] which recommended that case management 
approaches were the most effective in achieving return to work (Box 1). This paper presents results of 
an evaluation of a the health effects (with cost-utility estimates) of a pilot case management service 
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for long-term IB recipients commissioned by a Primary Care Trust (PCT) in the North East of England 
in 2009 (where 8.4% of the working age population receives IB). The intervention was informed by the 
NICE guidance and although it pre-dated the Black Review [10] and the Independent Review of 
Sickness Absence [11], the evaluation can make a timely and valuable contribution to the current 
policy debate about workplace health and sickness absence.  
 
Method 
Study Design 
The case management intervention and a comparison group were compared prospectively in a non-
equivalent group, repeated measures design using questionnaires at base line (T1), 3 months (the 
intervention’s midpoint, T2), 6 months (the intervention’s endpoint, T3) and 9 months (three months 
post-intervention, T4). Within the pilot design, differences between groups were explored using a 
range of generic and disease-specific outcomes as well as health behaviours. Tentative retrospective 
cost-utility analysis was also conducted. 
 
Case Management Intervention Group 
The service was delivered by a commissioned agency to provide a ‘health first’ biopsychosocial case 
management approach for long-term IB recipients (of 3 years or more). Telephone and face-to-face 
techniques were used to address health needs (including behaviours) and any other related barriers 
to health or employment (such as debt or housing). The scheme was intended to complement 
mainstream services with case-managers signposting to NHS, Department for Work and Pensions 
(DWP) and other services. They also enrolled patients directly onto specially commissioned 
physiotherapy and counselling services. Patients were referred onto the programme by other NHS 
services (such as the Alcohol Service), their GPs, or they could self-refer (19.8%). The length of 
engagement with the service varied according to the needs of each service user (six months 
average). Participants were discharged when they were assessed to be ready to enter mainstream 
services such as Pathways to Work or community health services.   
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Non-Equivalent Comparison Group 
A comparison group were recruited through IB ‘Choices’ events run by the regional Job Centre Plus. 
IB ‘Choices’ events offered a consistent sampling frame as all of those eligible within a given 
postcode area (IB receipt > 3 years) were invited to the event and attended on a voluntary basis.  It is 
possible that those in the comparison group were therefore more motivated than the majority of the IB 
population. The comparison group received usual NHS care via general practice as well as usual 
access to Department for Work and Pensions activities. This included access to Pathways to Work, 
other vocational services and usual community health services (such as mental health services).  
 
Data Collection 
Socio-demographic (gender, age, housing tenure), social capital (contact with family and friends and 
participation with the wider community) and work history (previous jobs time spent in the job, time 
spent on IB) data were collected for both groups with questions taken from national surveys such as 
the General Household Survey (GHS). These data were collected to further understand the client 
group in relation to the regional and UK population norms and because such factors might impact on 
the effectiveness of the intervention (e.g. there is a strong relationship between occupational status 
and health outcomes, [13]). General health was measured via EQ5-D and EQ-VAS. General physical 
health was measured using SF-8 PCS (a shorter version of SF-36) and general mental health was 
measured using the SF-8 MCS. Two more condition specific measures - the Hospital Anxiety and 
Depression Scale (HADS), and the Nordic Musculoskeletal questionnaire - were also included as the 
two largest clinical categories of IB recipients in the UK are those with mental health or 
musculoskeletal issues. Data on health behaviours (tobacco and alcohol consumption) were also 
collected. (See Box 2).  
 
Statistical Analysis 
For this pilot study a hypothesis generating (rather than testing) approach was adopted, with the focus 
on inferences generated from the most parsimonious models for health outcomes. The repeated 
observations from individuals at the different time points imply inherent dependency in the data, which 
was accounted for through a fixed effect linear model with correlated errors (Repeated Measures 
ANOVA). The models assume time-related improvements of the health outcomes with either constant 
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or non-constant rates of improvement during both the intervention and post-intervention periods. We 
used models with linear trends (intercept and slope) for constant rate of improvement of the health 
outcomes and models with quadratic effects to capture non-constant rate of improvement with decline 
in health outcome post-intervention. Likelihood ratio test statistics were used to choose between 
models with linear or quadratic trends for each of the health outcome accounting for other factors at 
baseline - notably gender and age – that remained significant after adjusting for time, age and gender.  
We investigated for each health outcome, whether the correlation of the errors was constant or time 
dependent in order to choose an optimum covariance structure for each outcome. Based on the most 
parsimonious model for each health outcome, we investigated whether the rates of improvement in 
health of the intervention group over time (in months) differed from that of the comparison group 
accounting for other factors such as gender and age. In addition, we sensitized the models for 
deviation from Gaussian distribution assumptions by obtaining bootstrap-based confidence intervals. 
The effects of missing observations were investigated by using multiple imputations. Analyses for 
binary response (Yes/No) for Smoking and Drinking were analysed using Generalised Estimating 
Equations (GEE) whilst the number of smoking per day and units of drinks per week were analysed 
using fixed effects models with correlated errors. Descriptive statistics were analysed in SPSS® 
software, fixed effect linear models with correlated errors were performed using `nlme’ package in R 
and the sensitivity for missing data was done using SAS/STAT® software. 
 
Results 
Participation 
From October 2009 to March 2012, 459 participants received the case management intervention.  Of 
these, 131 participants recruited between September 2009 and June 2010 were included in the 
evaluation of health outcomes. For the comparison group, 229 participants were recruited in the same 
period from 1429 attendees at IB ‘Choices’ events (16%). Baseline details for the intervention and 
comparison groups are shown in Table 1. The groups were statistically comparable in terms of 
gender, occupational class, time unemployed and smoking behaviour, but differed in age, marital 
status, use of social housing, primary health problem and use of alcohol. Intervention participants 
were more likely to have primarily mental health problems and worse health scores. However, using 
likelihood ratio test statistics to evaluate the importance of these baseline differences found no 
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significant association between them and health outcomes after adjusting for time, age and gender so 
they were not included in the final analysis. The completeness of follow-up data is shown in Table 2, 
with the effect upon findings of missing data assessed by imputation in relation to T2 where there was 
a low intervention group response (n=44). The number of participants was included in the analysis as 
they were to retain as much power as possible since our statistical approach allows the patients to 
contribute proportionally to their available data. The imbalance in numbers between the intervention 
and comparison groups constitutes more statistical power than forcing a balanced number of 
participants in both groups, which would have resulted in most of the observed data to be left unused. 
 
Intervention effects 
The comparative effect upon participants and non-participants is reported in Table 3. For each 
outcome a regression model provides age and gender adjusted estimates. Each model allows for 
linear (Time) and non-linear (Time
2
) effects and for the incremental effect of the intervention as a 
constant (Int), linearly (Int.Time) and non-linearly (Int.Time
2
) over time. Whilst the health of the 
comparison group remained stable, the general health (EQ5D, EQ-VAS) and the mental health 
(HADS-A, HADS-D, SF-8 MCS) of the intervention group improved, although this health improvement 
was less evident in terms of physical health (SF-8 PCS). There was no improvement in the 
musculoskeletal (Nordic 2) outcome (38% of participants in the intervention group had these problems 
as their primary health condition). There was no improvement in health behaviours in the intervention 
group and alcohol consumption actually increased.  
 
The impact on EQ-5D of the intervention over time is shown in Figure 1. Variation in response at each 
time point is shown as error bars (95% confidence intervals) and the predicted (model) changes over 
time are shown as lines. There was a statistically significant difference at baseline between the 
intervention and the comparison group, with the intervention group reporting a poorer state of health: 
0.30 (95%CI: 0.24 to 0.36) versus 0.42 (95%CI: 0.37 to 0.46). After six months, the EQ5D score of 
the intervention group had improved to a level similar to the comparison group, a gain persisting at 9 
months (T4). The model-based inference assumes data distributions are Gaussian distribution, 
although bootstrap (non-parametric) methods produced comparable confidence intervals. The 
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missingness mechanism satisfied the assumption that incomplete data were missing at random 
(MAR) and thus incompleteness does not appear to influence the findings. 
 
A similar pattern to EQ-5D was found for the EQ-VAS (Visual Analogue Scale) and the HADS-D 
scores. Unlike these measures, the HADS-A (figure 2) was best modelled by a linear improvement 
over time in the intervention group compared to the comparison group; the SF8 MCS was similar. No 
comparative changes were found for the Nordic-2 measure or SF8-PCS.  
 
Cost-utility estimation 
The case management intervention was delivered to a total of 459 participants at a cost of 
£1,161,047, or £2,530 per participant. Contemporary use of other healthcare and social resources 
used by the two groups was not recorded. Additionally, if the intervention had resulted in greater 
return to work this may have substantially offset the intervention costs, but this is not known. If 
baseline health outcomes were stable in the time preceding intervention then changes may be 
reasonably attributed to the intervention since no contemporaneous change occurred in the 
comparison group. Using trapezoidal estimation, the increase in quality of life (EQ-5D) shown in 
Figure 1 was estimated at 0.108 QALYs per participant within the study duration, providing a tentative 
cost-utility estimate of £23,500/QALY. This might be argued to be too conservative since there would 
be some continued benefit beyond the duration of follow-up. Extrapolating the model prediction to 14 
months (when the curve returns to the baseline value) provides a higher estimate of 0.152 QALYs 
and cost-utility estimate of £16,700/QALY. These estimates are necessarily retrospective and 
approximate as the study was not specifically designed to test cost-utility. Subsequent research 
should capture other key resources - use of other health, social service, and return to work services.  
 
Discussion 
Main finding of this study 
Those recruited to the case management intervention were initially in worse health than those in the 
comparison group, ascertained by generic (EQ-5D, EQ-VAS) and mental health scores (HADS-A, 
HADS-D, SF-8 MCS) and they exhibited worse health behaviours. By the end of the intervention their 
health had improved to levels of health similar to the comparison group. However both group’s scores 
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remained well below the UK population norms for the selected health measures and both intervention 
and comparison group participants remained in receipt of IB. In contrast to generic and mental health 
improvements, impact upon physical health and musculoskeletal problems was limited with no 
improvements in the musculoskeletal (Nordic 2) outcome. This meant that the intervention was not 
effective in addressing the primary health condition of 38% of the intervention participants. These 
positive findings need to be understood in relation to the limitations of the study as detailed below. 
 
The intervention was potentially cost-effective (in terms of the EQ-5D outcome) given current national 
policies for investment as the lower estimate of £16,700/QALY is below the threshold of 
£20,000/QALY given by NICE for case-management interventions that result in >=1% return to work 
rate [12]. A statement on whether the intervention is cost-effective though cannot be made until a 
comparative alternative study (e.g. longer-case management period) is undertaken. We also cannot 
state whether the estimate is generalisable to the whole IB population due to the methods of 
recruitment into the study including the proportion of self-referred patients who may be more 
motivated and thus more likely to experience a health improvement. These findings should be 
replicated using a more robust study design including use of randomisation to enhance attribution. 
 
What is already known on this subject? 
There is already considerable evidence about the successful use of case management approaches in 
health and social care, and in the provision of vocational support for those with long term health 
problems [12; 14; 15; 16]. However, no studies to date have evaluated the effectiveness of case 
management approaches for health improvement amongst people in long-term receipt of IB in 
England. As noted earlier, the need to find new and effective interventions to improve the health of 
those on long-term sickness benefits has been of increasing concern to successive UK governments 
[10; 11]. The intervention evaluated here builds on previous initiatives such as the Condition 
Management Programme (CMP). Whilst CMP was not regarded as wholly successful by the 
Department for Work and Pensions (DWP), the NHS found value in “case management coupled with 
group and individual interaction” [17: p28). Our evaluation also suggests that case management could 
have beneficial health effects for those in long term receipt of IB suggesting that CMP and related 
interventions could be useful components of the new DWP commissioned Work Programme. 
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However, whilst NICE evidence suggests that case management can be effective for both 
musculoskeletal and non-musculoskeletal conditions [12], within our study there appears to have 
been no improvement for those with musculoskeletal issues. This may have been because the 
service was not intensive enough, of sufficient duration or because the point of intervention (after 3 
years on IB) was too late. There is evidence to suggest that musculoskeletal conditions require early 
intervention and that longer absence from work diminishes intervention effectiveness [18]. The 
association between musculoskeletal conditions and mental health also needs to be considered [19, 
20, 21] with 43% of the intervention group reporting at baseline that they experienced both. So, those 
participants with a primary musculoskeletal condition may still have benefitted from the intervention 
via an improvement in a secondary - mental health - condition.  
 
What this study adds 
This is the first study to conduct a longitudinal and comparative evaluation of a health improvement 
case management approach for long-term IB recipients in England. The study shows the potential 
positive impact upon health of case management over a nine-month timescale including post-
intervention follow-up and a cautious estimate of cost-utility for comparative purposes with future 
interventions.  
 
Limitations of the study  
The pilot study is limited to relatively small numbers of participants, voluntary participation in the 
intervention, the self-reported nature of the outcomes, low response at T2, and the non-randomised, 
non-equivalent study design. However, for a non-equivalent group design and key feature is not the 
comparability of the groups per se but how group measures change over time. The study also used 
validated health outcomes and provided a nine month follow-up. The QALY estimates are to be taken 
as with care due to fluctuating participation within the intervention group, the need to impute missing 
data values (particularly for T2) and the relatively small sample size. The analysis nonetheless 
indicates the scale of costs and utility to be expected in interventions of this nature.  
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Conclusion 
This pilot study provides support for the health improvement benefits of case management 
approaches for IB recipients and tentative evidence of potential cost-utility when compared with NICE 
guidance on case-management of long-term incapacity for work [12]. Generic and mental health 
measures consistently improved in the intervention group, although there were no improvements in 
musculoskeletal outcomes or health behaviours. However, large scale, preferably randomised, 
research is required to examine the robustness and generalisability of these findings to other 
populations [22].  
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Table 1: Baseline Characteristics of Survey Participants 
 Intervention, N=131 Comparison, N=229 P 
Gender     
Male 65 (50%) 115 (50%) 0.913 
Female  66 (50%) 114 (50%)  
Age    
Mean and range, years 45 (21-64) 49 (19-63) <0.001 
≤ 45 years  57 (44%) 65 (29%)  
Marital Status    
Married 41 (31%) 107 (48%) 0.012 
Divorced 32 (24%) 63 (28%)  
Single 45 (34%) 44 (19%)  
Tenure    
Renting 76 (58%) 132 (58%) 0.312 
Renting (Social Housing) 49 (60%) 116 (85%) <0.001 
Transport    
No motor vehicle access 62 (47%) 97 (42%) 0.361 
Occupational Class
 
(last job)    
Professional 7 (6%) 7 (3%) 0.152 
Intermediate 8 (6%) 20 (9%)  
Skilled Non Manual 8 (6%) 16 (7%)  
Skilled Manual 27 (21%) 33 (15%)  
Semi Skilled 27 (21%) 72 (32%)  
Unskilled 49 (39%) 74 (33%)  
Workless Households 97 (74%) 149 (65%) 0.078 
Time spent on IB/ESA    
Mean (months) 98 108 0.170 
Primary Health Problem    
Musculo-Skeletal 49 (38%) 110 (50%) <0.001 
Mental Health 62 (48%) 53 (24%)  
Digestive/Gastric 4 (3%) 23 (10%)  
Cardiovascular 7 (5%) 21 (10%)  
Respiratory 4 (3%) 5 (2%)  
Other 3 (2%) 10 (5%)  
Multiple (≥3) health problems 56 (43%) 130 (59%) 0.008 
Seen clinician in past 30 days 107 (82%) 183 (80%) 0.684 
Smoking and Drinking    
Regular Smokers  56 (43%) 83 (36%) 0.223 
Cigarettes per day (in smokers) 54 (19%) 83 (19%) 1.000 
Drinking Alcohol 80 (61%) 109 (48%) <0.001 
Units per week (in drinkers) 24.6(36.9) 18.6(38.2) 0.288 
Health Scores    
EQ5D 0.30 (0.34) 0.42 (0.33) 0.002 
EQ-VAS 42.08 (21.28) 46.45 (19.43) 0.048 
SF8-PCS 34.24 (11.59) 33.24 (9.38) 0.372 
SF8-MCS 33.72 (11.78) 36.86 (12.14) 0.018 
HADS-A 12.68 (4.14) 10.54 (4.96) <0.001 
HADS-D 10.70 (4.36) 8.85 (4.44) <0.001 
NORDIC-2 3.40 (2.55) 4.30 (2.60) 0.002 
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Table 2 Invention and Comparison Group completeness of data 
 Initial Questionnaire 
(T1) 
Recall 1 
(T2) 
Recall 2 
(T3) 
Recall 3 
(T4) 
Intervention Group 131 44 79 95 
Comparison Group 229 188 166 154 
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Table 3 Parameter estimates, standard errors, asymptotic and bootstrap  
confidence intervals for the health outcomes (p≤5% in bold)  
Outcome Parameter Estimates Std. 
Error 
Asymptotic   95% 
CI 
Bootstrap  95% CI 
Lower Upper Lower Upper 
E
Q
5
D
 
Intercept 0.728 0.093 0.546 0.910 0.545 0.890 
Gender 0.028 0.030 -0.031 0.087 -0.031 0.085 
Age -0.007 0.002 -0.010 -0.003 -0.010 -0.003 
Int -0.148 0.037 -0.221 -0.076 -0.221 -0.077 
Time 0.001 0.008 -0.015 0.018 -0.017 0.019 
Time
2
 0.000 0.001 -0.002 0.002 -0.002 0.002 
Int.Time 0.056 0.016 0.025 0.087 0.021 0.091 
Int.Time
2
 -0.004 0.002 -0.007 -0.001 -0.008 0.000 
E
Q
-V
A
S
 
Intercept 53.099 5.530 42.261 63.937 41.322 63.533 
Gender -2.307 1.770 -5.775 1.162 -5.977 1.194 
Age -0.119 0.108 -0.331 0.093 -0.328 0.123 
Int -4.899 2.239 -9.288 -0.509 -9.372 -0.541 
Time -0.313 0.636 -1.561 0.934 -1.595 0.883 
Time
2
 0.078 0.074 -0.067 0.222 -0.065 0.230 
Int.Time 3.842 1.180 1.528 6.155 1.639 6.196 
Int.Time
2
 -0.346 0.137 -0.614 -0.077 -0.632 -0.082 
H
A
D
S
-A
 
Intercept 12.351 1.414 9.580 15.123 9.863 14.875 
Gender 0.388 0.460 -0.541 1.289 -0.506 1.298 
Age -0.044 0.028 -0.098 0.011 -0.096 0.004 
Int 1.852 0.531 0.811 2.894 0.845 2.893 
Time -0.131 0.031 -0.191 -0.070 -0.188 -0.070 
Int.Time -0.131 0.051 -0.232 -0.031 -0.250 -0.018 
H
A
D
S
-D
 
Intercept 8.184 1.328 5.581 10.787 5.808 10.820 
Gender 0.514 0.433 -0.335 1.363 -0.337 1.327 
Age 0.008 0.026 -0.044 0.059 -0.045 0.055 
Int 1.794 0.493 0.829 2.760 0.846 2.854 
Time 0.038 0.093 -0.143 0.220 -0.124 0.200 
Time
2
 -0.009 0.009 -0.027 0.009 -0.025 0.008 
Int.Time -0.606 0.180 -0.959 -0.254 -1.001 -0.198 
Int.Time
2
 0.051 0.019 0.013 0.089 0.002 0.095 
N
O
R
D
IC
-2
 Intercept 0.097 0.705 -1.286 1.479 -1.093 1.481 
Gender -0.465 0.229 -0.915 -0.016 -0.938 -0.050 
Age 0.090 0.014 0.062 0.117 0.064 0.112 
Int -0.502 0.264 -1.020 0.015 -1.038 -0.009 
Time -0.002 0.016 -0.033 0.030 -0.032 0.031 
Int.Time 0.027 0.026 -0.024 0.079 -0.032 0.095 
S
F
8
-P
C
S
 
Intercept 47.294 2.885 41.640 52.949 40.744 53.380 
Gender 2.310 0.939 0.468 4.151 0.356 4.312 
Age -0.309 0.057 -0.420 -0.198 -0.432 -0.187 
Int -0.286 1.086 -2.415 1.844 -2.368 1.910 
Time 0.171 0.240 -0.299 0.641 -0.250 0.570 
Time
2
 -0.014 0.026 -0.064 0.036 -0.057 0.032 
Int.Time 1.678 0.432 0.830 2.525 0.736 2.547 
Int.Time
2
 -0.162 0.047 -0.255 -0.070 -0.262 -0.062 
S
f8
-M
C
S
 
Intercept 33.277 3.378 26.656 39.897 27.130 40.900 
Gender -0.610 1.091 -2.748 1.529 -2.730 1.444 
Age 0.087 0.066 -0.043 0.217 -0.059 0.205 
Int -3.032 1.303 -5.585 -0.478 -5.781 -0.446 
Time 0.259 0.100 0.063 0.454 0.067 0.455 
Int.Time 0.404 0.157 0.096 0.713 0.060 0.736 
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S
m
o
k
in
g
 
Intercept 0.743 0.622 -0.476 1.963 - - 
Gender 0.303 0.209 -0.107 0.712 - - 
Age -0.030 0.0123 -0.054 -0.006 - - 
Int 0.185 0.228 -0.262 0.634 - - 
Time 0.013 0.009 -0.005 0.030 - - 
Int.Time -0.017 0.018 -0.052 0.018 - - 
S
m
o
k
in
g
 
/d
a
y
 
Intercept 11.559 5.099 1.484 21.634 - - 
Gender 3.438 1.810 -0.138 7.014 - - 
Age 0.096 0.101 -0.104 0.296 - - 
Int 1.435 2.087 -2.689 5.560 - - 
Time -0.285 0.155 -0.590 0.019 - - 
Int.Time 0.111 0.240 -0.362 0.583 - - 
D
ri
n
k
in
g
 
Intercept 0.122 0.596 -1.046 1.290 - - 
Gender 0.637 0.191 0.264 1.011 - - 
Age -0.011 0.012 -0.034 0.012 - - 
Int 0.562 0.228 0.115 1.008 - - 
Time 0.055 0.015 0.025 0.084 - - 
Int.Time -0.080 0.027 -0.134 -0.027 - - 
U
n
it
s
/w
e
e
k
 Intercept 33.933 11.192 11.882 55.984 - - 
Gender 8.445 3.699 1.157 15.733 - - 
Age -0.492 0.216 -0.917 -0.066 - - 
Int 6.082 4.176 -2.146 14.310 - - 
Time -0.469 0.250 -0.961 0.024 - - 
Int.Time -0.466 0.409 -1.271 0.339 - - 
  
18 
 
Figure 1: Average possible health levels of EQ-5D for the intervention and comparison 
groups. The error bars represent the observed profile and the fitted lines represent 
the predicted profiles. 
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Figure 2: Average possible health levels of HADS-A for the intervention and 
comparison groups. The error bars represent the observed profile and the fitted lines 
represent the predicted profiles. 
  
9
1
0
1
1
1
2
1
3
1
4
Months after Intervention
H
A
D
S
 A
n
x
ie
ty
0 3 6 9
Intervention
Comparison
20 
 
Box 1: National Institute for Health and Clinical Excellence recommendation on return 
to work interventions for Incapacity Benefit recipients  [2, 10] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Who is the target population?  
People with health problems who are unemployed and claiming Incapacity Benefit or 
Employment Support Allowance.  
 
Who should take action?   
Department for Work and Pensions and other bodies or organisations which may commission 
services for those who are unemployed and claiming Incapacity Benefit or Employment Support 
Allowance.  
 
What action should they take?  
Commission an integrated programme to help claimants enter or return to work (paid or unpaid). 
The programme should include a combination of interventions such as: an interview with a 
trained adviser to discuss the help they need to return to work; vocational training, including that 
offered by New Deal for Disabled People (for example, help producing a curriculum vitae, 
interview training and help to find a job or a workplacement); a condition management 
component run by local health providers to help people manage their health condition; financial 
measures to motivate them to return to work (such as return-to-work credit); support before and 
after returning to work (this may include one or more of the following: mentoring, a job coach, 
occupational health support or financial advice).  
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Box 2: Detailed description of health measures 
 
EuroQol (EQ-5D) and (EQ-VAS) 
Two parts: a questionnaire and a ‘health thermometer’. The EQ-5D questionnaire asks participants 
about their mobility, ability to self-care, their ability to carry out their usual activities, pain and 
discomfort and anxiety and depression on the day when they are interviewed. The responses are 
converted to a value between 0 and 1. The higher the value is the better the health state. The second 
element is the Visual Analogue Scale, often known as a ‘Health Thermometer’.  Participants are 
asked to rate their health on the day they are interviewed on a scale of 0 -100. 0 represents the worst 
health state the participant can imagine, 100 represents the best health state they can imagine with 
50 representing the midpoint. 
 
Hospital Anxiety and Depression Scale (HADS) 
There are two parts: HADS-A (Anxiety) and HADS-D (Depression). Both ask participants to choose 
options that best describe how they are feeling. Both generate a score between 0-21.  A higher score 
indicates a higher degree of Depression. 
 
Quality Metric Short Form 8 (SF8) 
SF-8 is a measure of health that produces a physical health score (PCS) and a mental health score 
(MCS). Participants are asked 8 questions about their health during the past four weeks. These 
generate two scores, both between 0-100: the higher the score the better the health state. 
 
Nordic Musculoskeletal Questionnaire (element 2) 
There are three elements of which only the second element (Nordic-2) was appropriate to this study 
Nordic-2 is a measure of musculoskeletal problems over the preceding 7 days. Participants are asked 
whether they have had problems with different areas of the body. The measures produce a scores of 
between 0 (no problem) areas and 9 (nine problem areas).  
 
 
 
 
